This Corrigendum is being issued with reference to our letter dated July 28, 2025, with respect to the Annual Report for the Financial Year 2024-2025. With reference to the captioned ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GKB Ophthalmics has issued a corrigendum to its Annual Report for FY 2024-2025, following an earlier submission dated July 28, 2025. The company identified an inadvertent error on page 56 of the Annual Report related to the graph showing share price performance in comparison to the BSE Sensex. An updated Annual Report has been filed with the correction incorporated, and is also available on the company's website (www.gkb.net). The company clarified that this is not a material error and does not impact the financial statements in any manner. The Annual Report covers the 43rd AGM scheduled for August 21, 2025, to be held via video conferencing.
This is a routine, non-material correction limited to a graphical representation of share price versus the Sensex, with no impact on reported financials. Shareholders should not be concerned about any change in the company's financial position, and the stock price is unlikely to be affected by this corrigendum.